Serum Osteopontin Level Correlates with Carotid-Femoral Pulse Wave Velocity in Geriatric Persons
Table 2
Clinical characteristics and carotid-femoral pulse wave velocity levels of 93 geriatric adults.
Characteristic
Number (%)
cfPWV (m/s)
value
Gender
Male
63 (67.7)
10.07 ± 2.60
0.869
Female
30 (32.3)
10.17 ± 3.25
Diabetes
No
49 (52.7)
9.37 ± 2.52
0.007∗
Yes
44 (47.3)
10.92 ± 2.92
Dyslipidemia
No
49 (52.7)
9.50 ± 2.38
0.029∗
Yes
44 (47.3)
10.77 ± 3.11
Hypertension
No
56 (60.2)
9.93 ± 2.80
0.473
Yes
37 (39.8)
10.36 ± 2.85
ACE inhibitor
No
77 (82.8)
10.11 ± 2.83
0.973
Yes
16 (17.2)
10.08 ± 2.79
ARB
No
67 (72.0)
9.95 ± 2.80
0.409
Yes
26 (28.0)
10.49 ± 2.85
-Blocker
No
71 (76.3)
10.07 ± 2.09
0.841
Yes
22 (23.7)
10.21 ± 2.61
CCB
No
71 (76.3)
9.98 ± 2.74
0.457
Yes
22 (23.7)
10.49 ± 3.05
Statins
No
70 (75.3)
10.19 ± 2.91
0.583
Yes
23 (24.7)
9.82 ± 2.52
Fibrate
No
75 (80.6)
10.11 ± 2.84
0.937
Yes
18 (19.4)
10.06 ± 2.74
Data are expressed as means ± standard deviations. was considered statistically significant after Student’s -test. cfPWV, carotid-femoral pulse wave velocity; CAD, coronary artery disease; CHF, congestive heart failure; ACE, angiotensin-converting enzyme; ARB, angiotensin-receptor blocker; CCB, calcium-channel blocker.
